Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MediRX vs Remedy Meds

MediRX
Graded #207

Higher grade

vs+10.499999999999993
Remedy Meds
Graded #437

Lower grade

The verdict

MediRX takes it — 66.1/100 to 55.6/100.

MediRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MediRX is a telehealth weight-loss platform offering compounded GLP-1 injections — semaglutide starting at $149/month and tirzepatide starting at $199/month — plus NAD+ and a name-brand GLP-1 option.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMediRX +28
64
36
Dose & formulationMediRX +13
77
64
Clinical oversightMediRX +8
82
74
Labs & monitoringEven
53
53
FulfillmentMediRX +8
73
65
Contract termsRemedy Meds +21
20
41
MediRX · left barRemedy Meds · right bar

The numbers

MetricMediRXRemedy Meds
WeighScore66.1/10055.6/100
GradeCC
Scorecard rank#207#437
Semaglutide$149/mo (compounded)$299/mo (starting dose, compounded)
Tirzepatide$199/mo (compounded)$399/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
MediRX

Graded #207 · C

Strengths

  • LegitScript Certified — a meaningful trust signal for an online pharmacy
  • Named operating entity disclosed (MediRX, Inc., Wyoming)
  • Care and pharmacy fulfillment run on OpenLoop Health's licensed network
  • Low promotional first-month pricing — semaglutide first month as low as $70

Where it loses points

  • Doesn't publish the exact states it serves; telehealth rules vary by state
  • Ongoing monthly price rises after the promotional first month
  • Compounded semaglutide and tirzepatide injections — limited oral options
  • Specific compounding pharmacies aren't named beyond the OpenLoop network
Remedy Meds

Graded #437 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard